Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Koyuru Kurane"'
Publikováno v:
Pediatrics International
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c90512a49b8257ba9031cf6559140f7e
https://doi.org/10.1111/ped.14699
https://doi.org/10.1111/ped.14699
Autor:
Takanori Yamagata, Hitoshi Osaka, Narumi Omika, Kenji Kurosawa, Makiko Tajika, Masaru Shimura, Kazuhiro Muramatsu, Mari Kuwajima, Eriko F. Jimbo, Hiroko Shimbo, Kei Murayama, Koyuru Kurane, Masahide Goto
Publikováno v:
Brain and Development. 41:465-469
Mutations in the mitochondrial tRNAMet gene have been reported in only five patients to date, all of whom presented with muscle weakness and exercise intolerance as signs of myopathy. We herein report the case of a 12-year-old girl with focal epileps
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f4198da67f3e343f8fcfd6ca7ad82b34
https://doi.org/10.1016/j.braindev.2019.01.006
https://doi.org/10.1016/j.braindev.2019.01.006
Autor:
Toshiyuki Takahashi, Koyuru Kurane, Akihiko Miyauchi, Takanori Yamagata, Takahiro Ikeda, Hitoshi Osaka, Yuji Gunji, Yukifumi Monden, Daisuke Tanaka
Publikováno v:
Multiple Sclerosis and Related Disorders. 45:102320
Intravenous corticosteroids have been regarded as the first-line therapy of anti-myelin-oligodendrocyte glycoprotein antibody (MOG-Ab)-positive acute disseminated encephalomyelitis (ADEM). While steroids are the first-choice therapy, MOG-Ab-positive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0250ea612c4abeb15d43ad7cfbf8d20b
https://doi.org/10.1016/j.msard.2020.102320
https://doi.org/10.1016/j.msard.2020.102320
Autor:
Mari, Kuwajima, Masahide, Goto, Koyuru, Kurane, Hiroko, Shimbo, Narumi, Omika, Eriko F, Jimbo, Kazuhiro, Muramatsu, Makiko, Tajika, Masaru, Shimura, Kei, Murayama, Kenji, Kurosawa, Takanori, Yamagata, Hitoshi, Osaka
Publikováno v:
Braindevelopment. 41(5)
Mutations in the mitochondrial tRNA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6d0053dedd3438bedeea023f3aa8ad8f
https://pubmed.ncbi.nlm.nih.gov/30739820
https://pubmed.ncbi.nlm.nih.gov/30739820
Publikováno v:
Internal Medicine
A 76-year-old man complicated with end-stage renal disease had latent tuberculosis infection (LTBI), and isoniazid (INH) 300 mg daily was started to prevent reactivation of LTBI before using biologic agents for rheumatoid arthritis. On the 8th day af
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9785758c7221dd9365ccd88fb36d7aea
https://doi.org/10.2169/internalmedicine.1341-18
https://doi.org/10.2169/internalmedicine.1341-18